longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

European stocks "Eleven Arhats" | 1. Simao rose about 6.5% in January, Novo Nordisk fell over 2.7%, Sanofi, Roche, and SAP rose by more than 13% at most

Wallstreetcn
Jan 31, 2025 at 07:51 PM

On Friday (January 31), ASML Holding's stock price in Amsterdam (ASML.NA) closed up 2.26% at €722.70, with a cumulative increase of 6.48% in January.
Novo Nordisk's stock price in Copenhagen (NOVOB.DC) closed up 0.60% at 607.30 Danish Krone, with a cumulative decrease of 2.71% in January.
Novartis (NOVN.SW) closed up 1.90%, with a cumulative increase of 7.88% in January;
Sanofi (SAN.FP) closed up 0.75%, with a cumulative increase of 11.37% in January;
Roche Holding (ROG.SW) closed up 0.28%, with a cumulative increase of 11.94% in January;
AstraZeneca (AZN.LN) closed up 0.27%, with a cumulative increase of 8.37% in January;
GlaxoSmithKline's stock price in London (GSK.LN) closed up 0.21%, with a cumulative increase of 4.42% in January;
SAP (SAP.GR) closed up 0.17%, with a cumulative increase of 13.06% in January;
L'Oréal (OR.FP) closed down 1.39%, with a cumulative increase of 4.87% in January;
Nestlé (NESN.SW) closed down 1.53%, with a cumulative increase of 3.47% in January;
LVMH Group (MC.FP) closed down 1.72%, with a cumulative increase of 4.87% in January

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings

  • Mar 9, 2026 at 04:15 PMHandshake and reconciliation! Novo Nordisk withdraws lawsuit, Wegovy officially launches on the Hims & Hers platform
  • Feb 24, 2026 at 01:55 PMNovo Nordisk will significantly reduce the price of its weight loss drug in the U.S. next year, with a maximum reduction…
  • Feb 24, 2026 at 11:58 AMNovo Nordisk UBT251 shows impressive phase II clinical data in China, with a weight loss effect of nearly 20%
  • Feb 23, 2026 at 01:57 PMGlobal news you need to know before Monday's U.S. stock market opens
  • Feb 9, 2026 at 09:04 PMNovo Nordisk's weight loss drug advertisement was deemed "false or misleading" by the FDA, and the stock price hit a new…

Related Stocks

Novo Nordisk AS

Novo Nordisk AS

USNVO

-2.14%

NOVARTIS AG

NOVARTIS AG

USNVS

-0.23%

Roche

Roche

USRHHBY

-0.83%

LongbridgeAI